Genmab to Present Late-Stage Oncology Data at ASCO 2025

Genmab announced it will present new data at the 2025 ASCO Annual Meeting, focusing on its late-stage oncology portfolio. Key highlights include the ...
Home/KnloSights/Clinical Trial Updates/Genmab to Present Late-Stage Oncology Data at ASCO 2025